Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Fleming

Showing results (41-50 of 112) with videos related to

Pageof 12
Sort By:
Annual Review of Public Health|January 1, 1995
Statistical issues in the design of HIV vaccine trialsC Schaper, T R Fleming, S G Self, et al.
Investigational New Drugs|January 1, 1996
Phase II trial of trimetrexate in advanced esophageal cancer: a southwest oncology group studyT R Fleming, T D Brown, S W Ross, et al.
Cancer Treatment Reports|November 1, 1979
Phase II evaluation of maytansine in patients with advanced head and neck cancerE T Creagan, T R Fleming, J H Edmonson, et al.
Cancer Treatment Reports|November 1, 1987
Phase II trial of bisantrene in hepatocellular carcinoma: a Southwest Oncology Group StudyT D Brown, T R Fleming, R A Shildt, et al.
Cancer|November 1, 1979
Pulmonary resection for metastatic nonosteogenic sarcomaE T Creagan, T R Fleming, J H Edmonson, et al.
The New Zealand Medical Journal|October 10, 1998
Monitoring clinical trialsK Sharples, T R Fleming, S MacMahon, et al.
Investigational New Drugs|May 1, 1993
Phase II trial of amonafide in advanced pancreas cancer. A Southwest Oncology Group studyC G Leichman, C Tangen, J S Macdonald, et al.
Cancer|April 1, 1981
Radical retropubic prostatectomy and pelvic lymphadenectomy for high-stage cancer of the prostateH Zincke, T R Fleming, W L Furlow, et al.
Hepatology (Baltimore, Md.)|July 1, 1989
Prognosis in primary biliary cirrhosis: model for decision makingE R Dickson, P M Grambsch, T R Fleming, et al.
The Journal of Urology|June 1, 1984
Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for adenocarcinoma confined to the prostateR C Benson, K M Tomera, H Zincke, et al.
Pageof 12

Showing results (41-50 of 112) with videos related to

Sort By:
Pageof 12
Annual Review of Public Health|January 1, 1995
Statistical issues in the design of HIV vaccine trialsC Schaper, T R Fleming, S G Self, et al.
Investigational New Drugs|January 1, 1996
Phase II trial of trimetrexate in advanced esophageal cancer: a southwest oncology group studyT R Fleming, T D Brown, S W Ross, et al.
Cancer Treatment Reports|November 1, 1979
Phase II evaluation of maytansine in patients with advanced head and neck cancerE T Creagan, T R Fleming, J H Edmonson, et al.
Cancer Treatment Reports|November 1, 1987
Phase II trial of bisantrene in hepatocellular carcinoma: a Southwest Oncology Group StudyT D Brown, T R Fleming, R A Shildt, et al.
Cancer|November 1, 1979
Pulmonary resection for metastatic nonosteogenic sarcomaE T Creagan, T R Fleming, J H Edmonson, et al.
The New Zealand Medical Journal|October 10, 1998
Monitoring clinical trialsK Sharples, T R Fleming, S MacMahon, et al.
Investigational New Drugs|May 1, 1993
Phase II trial of amonafide in advanced pancreas cancer. A Southwest Oncology Group studyC G Leichman, C Tangen, J S Macdonald, et al.
Cancer|April 1, 1981
Radical retropubic prostatectomy and pelvic lymphadenectomy for high-stage cancer of the prostateH Zincke, T R Fleming, W L Furlow, et al.
Hepatology (Baltimore, Md.)|July 1, 1989
Prognosis in primary biliary cirrhosis: model for decision makingE R Dickson, P M Grambsch, T R Fleming, et al.
The Journal of Urology|June 1, 1984
Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for adenocarcinoma confined to the prostateR C Benson, K M Tomera, H Zincke, et al.
Pageof 12